Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C000509200 on August 31, 2000

J. Biol. Chem., Vol. 275, Issue 43, 33193-33196, October 27, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/43/33193    most recent
C000509200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterson, Y. K.
Right arrow Articles by Lanier, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterson, Y. K.
Right arrow Articles by Lanier, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
Stabilization of the GDP-bound Conformation of Gialpha by a Peptide Derived from the G-protein Regulatory Motif of AGS3*

Yuri K. Peterson, Michael L. BernardDagger, Hongzheng Ma§, Starr Hazard III, Stephen G. Graber§, and Stephen M. Lanier||

From the Departments of Pharmacology and  Library and Informatics, Medical University of South Carolina, Charleston, South Carolina 29403 and the § Department of Pharmacology and Toxicology, West Virginia University School of Medicine, Morgantown, West Virginia 26506

Received for publication, July 31, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The G-protein regulatory (GPR) motif in AGS3 was recently identified as a region for protein binding to heterotrimeric G-protein alpha  subunits. To define the properties of this ~20-amino acid motif, we designed a GPR consensus peptide and determined its influence on the activation state of G-protein and receptor coupling to G-protein. The GPR peptide sequence (28 amino acids) encompassed the consensus sequence defined by the four GPR motifs conserved in the family of AGS3 proteins. The GPR consensus peptide effectively prevented the binding of AGS3 to Gialpha 1,2 in protein interaction assays, inhibited guanosine 5'-O-(3-thiotriphosphate) binding to Gialpha , and stabilized the GDP-bound conformation of Gialpha . The GPR peptide had little effect on nucleotide binding to Goalpha and brain G-protein indicating selective regulation of Gialpha . Thus, the GPR peptide functions as a guanine nucleotide dissociation inhibitor for Gialpha . The GPR consensus peptide also blocked receptor coupling to Gialpha beta gamma indicating that although the AGS3-GPR peptide stabilized the GDP-bound conformation of Gialpha , this conformation of Gialpha GDP was not recognized by a G-protein coupled receptor. The AGS3-GPR motif presents an opportunity for selective control of Gialpha - and Gbeta gamma -regulated effector systems, and the GPR motif allows for alternative modes of signal input to G-protein signaling systems.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The G-protein regulatory (GPR)1 motif or GoLOCO repeat is a ~20-amino acid domain found in several proteins that interact with and/or regulate G-proteins (1, 2). Such proteins include the activator of G-protein signaling AGS3, the AGS3-related protein PINS in Drosophila melanogaster, two members of the RGS family of proteins, and three proteins (LGN, Pcp2, and Rap1GAP) isolated in yeast two-hybrid screens using Gialpha or Goalpha as bait. Rat AGS3 was isolated in a yeast-based functional screen designed to identify receptor-independent activators of heterotrimeric G-protein signaling (1). The AGS3-related protein PINS is required for asymmetric cell division of neuroblasts in D. melanogaster, where it is found complexed with Gi/Go (3, 4), but neither the signal input nor output for this complex is known. Some insight as to how PINS may regulate Gi/Go is provided by studies with AGS3 (1). In the yeast-based system, AGS3 selectively activated Gialpha 2 and Gialpha 3. The action of AGS3 as a G-protein activator in the yeast-based system was independent of nucleotide exchange as it was not antagonized by overexpression of RGS4, and it was still observed following replacement of Gialpha 2 with Gialpha 2-G204A, a mutant that is deficient in making the transition to the GTP-bound state (1, 5). Both of these manipulations effectively prevent receptor-mediated activation of G-protein signaling in the yeast system and block the action of AGS1, which was isolated in the same screen and apparently behaves as a guanine nucleotide exchange factor for heterotrimeric G-proteins (5, 6). These data indicate that the interaction of AGS3 with G-protein influences a unique control mechanism within the activation/deactivation cycle of heterotrimeric G-proteins.

AGS3 exists as a 650-amino acid protein enriched in brain and a 166-amino acid protein (AGS3-SHORT) enriched in heart (1).2,3 The 650-amino acid protein consists of two functional domains defined by a series of seven amino-terminal tetratrico peptide repeats (TPR) and four carboxyl-terminal GPR motifs. Site-directed mutagenesis, protein interaction studies, and subcellular localization experiments indicated that the GPR motifs of AGS3 were likely responsible for binding G-protein, whereas the TPR domain is a site for binding of regulatory proteins (1, 3, 4).2,3 AGS3 preferentially binds to Galpha in the presence of GDP (1). AGS3-GPR effectively competed with Gbeta gamma subunits for binding to Gtalpha and inhibited guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S) binding to Gialpha 1.2 Such an activity likely has significance in a number of aspects of G-protein-mediated signaling events and presents a novel opportunity to control the basal activity of G-protein signaling, as well as influence receptor-mediated activation of G-protein. These observations also raise many interesting questions relative to basic aspects of G-protein structure/function and alternative modes of regulation and functional roles for G-protein signaling systems in the cell. To address these issues, we generated a series of peptides based upon the consensus GPR motif in AGS3 and evaluated their effects on the nucleotide binding properties of Gialpha . A 28-amino acid GPR peptide effectively blocked the interaction of AGS3 with Gialpha and inhibited GTPgamma S binding to Gialpha by a mechanism that involved stabilization of the GDP-bound conformation of Gialpha . The GPR consensus peptide also blocked receptor coupling to Gialpha beta gamma indicating that although the AGS3-GPR peptide stabilized the GDP-bound conformation of Gialpha , this conformation of Gialpha GDP was not recognized by a G-protein-coupled receptor.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Materials-- 35S-GTPgamma S (1250 Ci/mmol), 3H-GDP (29.6 Ci/mmol), and 3H-5-hydroxy tryptamine (HT) (21.8 Ci/mmol) were purchased from PerkinElmer Life Sciences. Peptides were synthesized and purified by Bio-Synthesis, Inc. (Lewisville, TX), and peptide mass was verified by matrix-assisted laser desorption ionization mass spectrometry. GDP, GTPgamma S, and 5-HT were obtained from Sigma. Acrylamide, bisacrylamide, protein assay kits, and sodium dodecyl sulfate were purchased from Bio-Rad. Ecoscint A was purchased from National Diagnostics (Manville, NJ). CytoScint was purchased from ICN Biomedicals (Costa Mesa, CA). Thesit (polyoxyethylene-9-lauryl ether) was obtained from Roche Molecular Biochemicals. Polyvinylidene difluoride membranes were obtained from Pall Gelman Sciences (Ann Arbor, MI). Nitrocellulose BA85 filters were purchased from Schleicher & Schuell (Keene, NH). Whatman GF/C FP200 filters were purchased from Brandel Inc.(Gaithersburg, MD). Purified bovine brain G-protein was kindly provided by Dr. John Hildebrandt (Department of Pharmacology, Medical University of South Carolina) (7). All other materials were obtained as described elsewhere (1, 8).

Protein Interaction Assays-- The GPR domain of AGS3 (Pro463-Ser650) containing the four GPR motifs was generated as a glutathione S-transferase fusion protein by polymerase chain reaction using the full-length cDNA of AGS3 as a template. The AGS3-Pro463-Ser650 segment was also cloned into the pQE-30 vector (Qiagen, Valencia, CA) to generate an amino-terminal His-tagged protein. His-tagged AGS3 was expressed in and purified from bacteria using a nickel affinity matrix (ProBondTM resin; Invitrogen, Carlsbad, CA). The His-tagged AGS3 was eluted from the matrix with imidazole and desalted by centrifugation as with the GST fusion protein (1). The interaction of GST-AGS3-GPR and HIS-tagged AGS3-GPR with G-proteins was assessed by protein interaction experiments using purified G-protein as described previously (1). Gialpha 1-3 and Goalpha were purified from Sf9 insect cells infected with recombinant virus as described (8). All purified G-proteins used in these studies were isolated in the GDP-bound form, and G-protein interaction assays contained 10 µM GDP.

A separate series of protein interaction experiments were designed to determine whether the Gialpha complexed with AGS3 contained bound GDP. Gialpha 1 (100 nM) was loaded with 3H-GDP (0.5 µM; 2.0 × 104 dpm/pmol) by incubation for 20 min at 24 °C in binding buffer (50 mM Hepes-HCl, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 50 µM adenosine triphosphate, and 10 µg/ml bovine serum albumin). The 3H-GDP-loaded Gialpha 1 was incubated with 300 nM GST or GST-AGS3-GPR in the presence and absence of 10 µM GPR peptide and processed as described (1). The washed resin containing bound proteins was transferred to vials for measurement of 3H-GDP by liquid scintillation spectroscopy.

GTPgamma S Binding Assays-- GTPgamma S binding assays were generally conducted as described (9). G-proteins (100 nM) were preincubated for 20 min at 24 °C in the presence and absence of GPR peptides. Binding assays (duplicate determinations) were initiated by addition of 0.5 µM GTPgamma S (4.0 × 104 dpm/pmol), and incubations (total volume = 50 µl) were continued for 30 min at 24 °C. Both preincubations and GTPgamma S binding assays were conducted in binding buffer containing 2 mM MgCl2. Reactions were terminated by rapid filtration through nitrocellulose filters with 4 × 4-ml washes of stop buffer (50 mM Tris-HCl, 5 mM MgCl2, 1 mM EDTA, pH 7.4, at 4 °C). Radioactivity bound to the filters was determined by liquid scintillation counting. Nonspecific binding was defined by 100 µM GTPgamma S.

GDP Dissociation Assays-- Gialpha 1 (100 nM) was loaded with 3H-GDP (0.5 µM; 2 × 104 dpm/pmol) by incubation for 20 min at 24 °C in binding buffer without MgCl2. 45-µl aliquots of the preincubation mixture (~500,000 dpm) were then added to incubation tubes containing 5 µl of vehicle or peptide, and samples were incubated for 30 min at 24 °C. Two sets of tubes were set up for each time point to be analyzed. Each set contained duplicate samples for determination of total binding, nonspecific binding, or binding in the presence of peptide. For each time point, one set of tubes served as an internal time control, whereas the other set received added GTPgamma S or GDP to initiate dissociation. Data are expressed as % of control, where control represents the level of 3H-GDP binding at each time point in the set of tubes that did not receive added nucleotide to initiate dissociation. The amount of 3H-GDP bound following the 20-min preincubation (~30,000 dpm) was identical to that observed at the 30-min incubation time point following addition of vehicle or peptide. 3H-GDP dissociation was initiated by addition of GTPgamma S or GDP in a volume of 5 µl (final concentration, 100 µM). Reactions were terminated at specified time points by rapid filtration through nitrocellulose filters (BA85; Schleicher & Shuell) with 4 × 4-ml washes of stop buffer. Radioactivity bound to the filters was determined by liquid scintillation counting. Nonspecific binding was defined by 100 µM GDP.

High Affinity Agonist Binding-- Sf9 cell membranes expressing 5-HT1A receptors were reconstituted with Galpha beta gamma , and high affinity agonist binding was measured with 3H-5-HT as described previously (8, 10). Membrane aliquots (100 µg of membrane protein, 85 nM receptor) were preincubated for 15 min at 25 °C with G-proteins (2125 nM Galpha beta gamma ) with or without GPR peptides in a total volume of 17 µl (reconstitution buffer, 5 mM NaHEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 500 nM GDP, 0.04% CHAPS, pH 7.5). The reconstitution mixtures were then diluted 10-fold with binding buffer (50 mM Tris-HCl, 5 mM MgCl2, 0.5 mM EDTA, pH 7.5), and 50 µl were added to binding tubes (total volume = 150 µl) containing 2 nM 3H-5-HT. The final concentrations of receptor, G-protein, and peptide in the binding tubes were 2.8 nM, 70.8 nM, and 114 µM, respectively. Nonspecific binding was determined in the presence of 100 µM 5-HT. Binding reactions were incubated at 25 °C for 1.5 h and terminated by filtration over Whatman GF/C FP200 filters using a Brandel cell harvester. The filters were rinsed thrice with 4 ml of ice-cold washing buffer (50 mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA, 0.01% sodium azide, pH 7.5, at 4 °C), placed in 4.5 ml of CytoScint, and counted to constant error in a scintillation counter.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The ~20-amino acid GPR motif is repeated four times in AGS3-related proteins, with the exception of the three repeats found in the Drosophila protein PINS (Fig. 1). Alignment of the four GPR repeats from five species revealed a GPR consensus sequence (Fig. 1). The GPR consensus sequence is characterized by the upstream negative charge (Glu-Glu) and hydrophobic cluster (Phe-Phe), Leu/Met10, Leu/Ile11, Gln15, Ser/Ala16, Arg18, Met/Leu19, and the Asp-Asp-Gln-Arg sequence at the carboxyl end of the motif. Helical wheel and Chou-Fasman analysis indicated that this region is capable of existing as an amphipathic helix. Each of the GPR motifs illustrated in Fig. 1 possess a varying number of Proline residues just after and in some cases before the core consensus sequence, which may exert an important influence within the overall organization of the four GPR motifs. As part of an effort to define the structural basis of the interaction of AGS3 with Gialpha and the functional consequences of this interaction, we asked whether a consensus sequence peptide effectively interacted with Gialpha .


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 1.   Alignment of the GPR motifs found in AGS3 and related proteins. The overall domain structure of AGS3 (650-amino acid protein) is indicated at the top of the figure. The hashed boxes represent the TPR domain. The GPR domains of rat AGS3 (AAF08683), human AGS3 (CAB55951), the D. melanogaster PINS protein (AAF36967), the Caenorhabditis elegans protein (CE) (AAA81387), and the Tetraodon nigroviridis (puffer fish) protein (AL338846) were aligned by PILEUP (Genetics Computer Group Wisconsin Package) and visual adjustment. A consensus amino acid was defined by the presence of an amino acid or closely related residue in all four GPR repeats.

The core GPR consensus sequence was bracketed by additional residues (three amino terminus, five carboxyl terminus) derived from AGS3-GPR-IV, and the carboxyl terminus was amidated (Fig. 1). The 28-amino acid GPR consensus peptide completely blocked the binding of Gialpha 1 or Gialpha 2 to GST-AGS3-GPR with an IC50 of ~200 nM (Fig. 2A and B). The GPR consensus peptide also inhibited GTPgamma S binding to Gialpha 1 and Gialpha 2 (IC50 ~200 nM) (Fig. 2, C and D) consistent with the preferential binding of AGS3 to Gialpha in the presence of GDP (1). The inhibitory effect of the GPR consensus peptide on GTPgamma S binding was selective for Gialpha as it only minimally affected nucleotide binding to Goalpha or brain G-protein (Fig. 2D). The activity of the GPR consensus peptide in both the protein interaction assays and GTPgamma S binding assays was lost upon substitution of Phe for the highly conserved Arg23 (Fig. 2, B, C, and D). However, substitution of Ala for the invariant Gln15 did not alter the activity of the GPR peptide (Fig. 2B).4 Similar results were obtained when these amino acid substitutions were made in the context of GST-AGS3 fusion protein, which contained the terminal 74 amino acids of AGS3 including part of GPR-III and all of GPR-IV (Fig. 1) (1).2


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Influence of GPR peptides on the interaction of GST-AGS3-GPR with Gialpha and GTPgamma S binding to Gialpha . A and B, the carboxyl region of AGS3 (Pro463-Ser650) containing all four GPR repeats was generated as a His-tagged (A) or GST fusion (B) protein for protein interaction assays as described under "Experimental Procedures." All interactions were done in the presence of 10 µM GDP, and the input lanes represent one-tenth of the G-protein used in each interaction assay. A, Gialpha 1 (75 nM) was incubated with 300 nM His-tagged AGS3-GPR in the absence and presence of increasing amounts of the GPR peptide, after which bound Gialpha was isolated on a nickel affinity matrix, and samples were processed for immunoblotting with Gialpha antisera. The blot in the upper panel of A was stripped and reprobed with AGS3 antisera to provide internal controls for protein loading. B, Gialpha 2 (75 nM) was incubated with 300 nM AGS3-GPR or GST in the presence and absence of 100 µM GPR consensus peptide, GPR peptide Q15A, or GPR peptide R23F. The immunoblots presented in A and B are representative of three experiments. C and D, GTPgamma 35S binding to G-proteins (100 nM) was measured in the absence and presence of peptides as described under "Experimental Procedures." Data are expressed as the percent of specific binding (~5 pmol) observed in the absence of peptide and represent the means ± S.E. derived from three experiments. The concentration of peptides in D is 10 µM.

We then addressed the mechanism by which the GPR consensus peptide inhibited GTPgamma S binding to Gialpha 2 and determined the effect of the GPR motif on receptor coupling to G-protein. The inhibition of GTPgamma S binding to Gialpha by the GPR consensus peptide may reflect a reduction in the rate of nucleotide exchange. Indeed, the rate of GDP dissociation was markedly diminished in the presence of the GPR consensus peptide (Fig. 3A).5 The R23F mutation, which eliminated the effectiveness of the peptide to block interaction of AGS3 with Gialpha and GTPgamma S binding to Gialpha , also did not alter GDP dissociation (Fig. 3A). The inhibition of GDP dissociation by the GPR consensus peptide suggests that the GPR motif is stabilizing the GDP-bound conformation of Gialpha . To address this issue we evaluated the interaction of GST-AGS3-GPR with Gialpha 2, which had been preloaded with 3H-GDP. Subsequent analysis of the G-protein complexed with AGS3-GPR on the glutathione affinity matrix indicated that the nucleotide binding site of G-protein bound to AGS3 indeed contained GDP (Fig. 3B). Gialpha GDP binding to AGS3-GPR was blocked by the GPR consensus peptide (Fig. 3B) consistent with the ability of this peptide to inhibit interaction of GST-AGS3-GPR with Gialpha 1/2 (Fig. 2, A and B).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Stabilization of the GDP-bound conformation of Gialpha 2 by the GPR consensus peptide. A, 3H-GDP dissociation from Gialpha 2 (100 nM). Gialpha 2 was loaded with 3H-GDP, and dissociation was initiated by addition of GTPgamma S (100 µM) as described under "Experimental Procedures." Data are expressed as the percent of specific binding observed in control samples for each time point that did not receive 100 µM GTPgamma S. The peptide concentration was 10 µM. B, Gialpha 2 (100 nM) was loaded with 3H-GDP and incubated with 300 nM GST or GST-AGS3-GPR in the presence and absence of 10 µM GPR consensus peptide and processed for protein interactions as described under "Experimental Procedures." The proteins bound to the glutathione affinity matrix were eluted, and the amount of bound GDP was measured by liquid scintillation spectroscopy. Data in A and B are presented as the means ± S.E. derived from three experiments.

The stabilization of the GDP-bound conformation of Gialpha by the GPR consensus peptide indicates that the AGS3-GPR motif can influence subunit interactions by interfering with Gbeta gamma binding to Gialpha .2 This apparent effect may account for the results obtained in protein interaction assays using GST-AGS3-GPR and brain lysates, where Gbeta gamma is absent from the AGS3-Gialpha complex (1). The influence of the GPR motif on subunit interactions would have significant implications for signal processing. First, interaction of the AGS3-GPR motif with Galpha beta gamma would release Gbeta gamma for regulation of downstream signaling events, while stabilizing Galpha GDP (1). Such a mode of signal input may be of utility where there is a need for selective regulation of Gbeta gamma -sensitive effectors. The time frame for termination of such a signaling event (i.e. reassociation of Gbeta gamma with Gialpha GDP) likely differs from that of a more typical signaling event in which there has been an exchange of nucleotide bound to Gialpha , and signal termination involves GTP hydrolysis along with subunit reassociation. A second implication of stabilization of Galpha GDP by a GPR domain is related to receptor G-protein coupling. We addressed this issue experimentally using a membrane assay system where receptor-G-protein coupling is reflected as high affinity binding of agonists. The high affinity binding of agonist observed upon reconstitution of the membrane-bound 5-HT1 receptor with Gialpha beta gamma was inhibited by addition of the GPR peptide (Fig. 4). This action of the GPR peptide was not observed with the R23F peptide and was selective for Gi versus Go (Fig. 4).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Influence of GPR peptides on receptor interaction with G-proteins. Sf9 cell membranes expressing 5-HT1A receptors were reconstituted with G-proteins in the presence and absence of GPR peptides as described under "Experimental Procedures." The final concentration of peptide was 114 µM. Radioligand binding assays used a concentration of 3H-5HT near the Kd for the high affinity, guanosine 5'-(beta ,gamma -imido)triphosphate-sensitive binding site (8, 10). The control bar indicates the amount of agonist binding observed in the absence of added G-protein. Data are presented as the mean ± S.E. from four independent experiments.

The influence of the single amino acid substitution on the bioactivity of the GPR both within the context of a short peptide and a GST fusion protein containing an additional 74 amino acids of AGS3 sequence strongly suggest a relatively discrete and specific surface interaction with Gialpha (Fig. 2) (1).2,6 Helical wheel projections and 3D models indicated that when the GPR consensus peptide is fixed in an alpha  helical conformation, the Phe8, Ala12, Gln15, Met19, and Arg23 residues are on the same face of the helix. On this face of the helix is a hydrophobic sector defined by Phe8, Ala12, and Met19 that is bound by polar residues, which may be involved in charge pairing to residues in Gialpha . As was the case for the R23F substitution, disruption of this hydrophobic sector by substitution of Arg for Phe8 also resulted in a loss of activity for the GST-AGS3-GPR fusion protein in GTPgamma S binding and protein interaction assays (1).2 Thus, either extension (R23F substitution) or shortening (F8R) of the hydrophobic sector on this face of the helix resulted in a loss of bioactivity for the GPR motif. In contrast, strengthening of this hydrophobic sector by substitution of Ala for Gln15 did not alter the activity of the GPR peptide. These data indicate an important role for a spatially constrained hydrophobic stretch of ~16.6 Å that is key for peptide interaction with Gialpha .

The inability of receptor to productively couple to Galpha GDP-GPR is of interest. The Galpha GDP conformation stabilized by the GPR peptide may differ from that stabilized by Gbeta gamma in such a manner that the receptor cannot recognize Galpha . Indeed, the orientations of the amino and carboxyl domains of Gialpha 1, which are important interaction sites with receptor, are quite different in the Gialpha GDP and Gialpha GDPbeta gamma structures (11-13). In addition to such differences in the structural orientation of Gialpha domains interacting with receptor, it is likely that receptor contact points on Gbeta gamma also play a role in receptor-mediated activation of guanine nucleotide exchange (14-18). Alternatively, the receptor may indeed interact with the Galpha GDP-GPR complex, but this interaction stabilizes a receptor conformation with low affinity for agonist (19). Ultimately, one may think of the Galpha GDP-GPR complex as a type of dimeric G-protein, and it is not clear what might provide signal input to such a complex.

Although the GPR motif is present in several proteins that interact with Galpha and/or regulate nucleotide binding/hydrolysis (1, 2), these proteins have different and often opposing effects on the activation state of G-protein (20, 21).2,5 Pcp2, which contains two GPR motifs based upon this consensus sequence, actually appears to increase the dissociation of GDP from Goalpha (21). Thus, there are either subtle differences in this motif or other residues outside of this motif that play a key role in the specific functional output gendered by interaction of the GPR motif with Galpha . Of note is the selective effects of the AGS3-GPR peptide for Gialpha versus Goalpha in both nucleotide binding assays and the analysis of receptor coupling to G-proteins. Further dissection of the structural basis for this selectivity will provide clues as to the site of interaction of the GPR peptide with Gialpha and the mechanism by which it stabilizes the GDP-bound conformation. One prominent area of sequence divergence between Goalpha and Gialpha encompasses switch IV, a region implicated in the formation of Gi1alpha GDP multimers (11).

The role of AGS3 as a GDI is an unexpected concept for heterotrimeric G-proteins, although such proteins serve similar regulator roles for Ras-related G-proteins. Proteins containing the AGS3-GPR motif may promote dissociation of Galpha and Gbeta gamma in the absence of nucleotide exchange and present an opportunity for selective control of Gialpha - and Gbeta gamma -regulated effector systems. GPR-containing proteins likely play a role in regulating basal activity of G-protein signaling systems in the cell and provide alternative modes of signal input to G-protein signaling systems that may either augment, complement, or antagonize G-protein activation by GPCRs.

    ACKNOWLEDGEMENTS

We thank Emir Duzic, Mary Cismowski, Nathalie Pizzinat, Michael Natochin, Nikolai Artemyev, and John Hildebrandt for valuable discussions. We appreciate the technical assistance of Jane Jourdan, Lori Flood, and Peter Chung.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants NS24821 and MH5993 (to S. M. L.) and National Science Foundation Grant MCB9870839 (to S. G. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a Medical Scientist Training Program fellowship supported by the National Institutes of Health (T32-GM08716).

|| To whom correspondence should be addressed: Dept. of Pharmacology, Medical University of South Carolina, 173 Ashley Ave., Charleston, SC 29403. Tel.: 843-792-2574; Fax: 843-792-2475; E-mail: laniersm@musc.edu.

Published, JBC Papers in Press, August 31, 2000, DOI 10.1074/jbc.C000509200

2 M. Bernard, Y. K. Peterson, P. Chung, and S. M. Lanier, submitted for publication.

3 N. Pizzinat, A. Takesono, and S. M. Lanier, submitted for publication.

4 Y. K. Peterson and S. M. Lanier, unpublished observations.

5 M. Natochin, B. Lester, Y. K. Peterson, M. L. Bernard, S. M. Lanier, and N. O. Artemyev, submitted for publication.

6 H. Ma, M. L. Bernard, S. M. Lanier, and S. G. Graber, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: GPR, G-protein regulatory; TPR, tetratrico peptide repeats; GTPgamma S, guanosine 5'-O-(3-thiotriphosphate); GDI, guanine nucleotide dissociation inhibitor; HT, hydroxy tryptamine; GST, glutathione S-transferase; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Takesono, A., Cismowski, M. J., Ribas, C., Bernard, M., Chung, P., Hazard, S., III, Duzic, E., and Lanier, S. M. (1999) J. Biol. Chem. 274, 33202-33205
2. Siderovski, D. P., Diverse-Pierlussi, M. A., and De Vries, L. (1999) Trends Biochem. Sci. 24, 340-341
3. Yu, F. W., Morin, X., Cai, Y., Yang, X. H., and Chia, W. (2000) Cell 100, 399-409
4. Schaefer, M., Schevchenko, A., Schevchenko, A., and Knoblich, J. A. (2000) Curr. Biol. 10, 353-362
5. Cismowski, M., Takesono, A., Ma, C., Lizano, J. S., Xie, S., Fuernkranz, H., Lanier, S. M., and Duzic, E. (1999) Nature Biotechnol. 17, 878-883
6. Cismowski, M., Ma, C., Ribas, C., Xie, X., Spruyt, M., Lizano, J. S, Lanier, S. M., and Duzic, E. (2000) J. Biol. Chem. 275, 23421-23424
7. Dingus, J., Wilcox, M. D., Kohnken, R., and Hildebrandt, J. D. (1994) Methods Enzymol. 237, 457-471
8. Clawges, H. M., Depree, K. M., Parker, E. M., and Graber, S. G. (1997) Biochemistry 36, 12930-12938
9. Ross, M., and Higashijima, T. (1994) Methods Enzymol. 237, 26-37
10. Bae, H., Anderson, K., Flood, L. A., Skiba, N. P., Hamm, H. E., and Graber, S. G. (1997) J. Biol. Chem. 272, 32071-32077
11. Mixon, M. B., Lee, E., Coleman, D. E., Berghuis, A. M., Gilman, A. G., and Sprang, S. R. (1995) Science 270, 954-960
12. Wall, M. A., Coleman, D. E., Lee, E., Iniguezlluhi, J. A., Posner, B. A., Gilman, A. G., and Sprang, S. R. (1995) Cell 83, 1047-1058
13. Sprang, S. R. (1997) Ann. Rev. Biochem. 66, 639-678
14. Wu, G., Hildebrandt, J., Benovic, J. L., and Lanier, S. M. (1998) J. Biol. Chem. 273, 7197-7200
15. Kleuss, C., Scherubl, H., Hescheler, J., Schultz, G., and Wittig, B. (1992) Science 358, 424-426
16. Taylor, J. M., Jacob-Mosier, G. G., Lawton, R. G., Remmers, A. E., and Neubig, R. R. (1994) J. Biol. Chem. 269, 27618-27624
17. Hildebrandt, J. D. (1997) Biochem. Pharmacol. 54, 325-339
18. Richardson, M., and Robishaw, J. D. (1999) J. Biol. Chem. 274, 13525-13533
19. Nanoff, C., and Freissmuth, M. (1997) Physiol. Res. 46, 79-87
20. Berman, D. M., and Gilman, A. G. (1998) J. Biol. Chem. 273, 1269-1272
21. Luo, Y., and Denker, B. M. (1999) J. Biol. Chem. 274, 10685-10688


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. An, J. B. Blumer, M. L. Bernard, and S. M. Lanier
The PDZ and Band 4.1 Containing Protein Frmpd1 Regulates the Subcellular Location of Activator of G-protein Signaling 3 and Its Interaction with G-proteins
J. Biol. Chem., September 5, 2008; 283(36): 24718 - 24728.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Xu, P. Sulaiman, R. M. Feddersen, J. Liu, R. G. Smith, and N. Vardi
Retinal ON Bipolar Cells Express a New PCP2 Splice Variant That Accelerates the Light Response
J. Neurosci., September 3, 2008; 28(36): 8873 - 8884.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. S. Bowers, F. W. Hopf, J. K. Chou, A. M. Guillory, S.-J. Chang, P. H. Janak, A. Bonci, and I. Diamond
Nucleus accumbens AGS3 expression drives ethanol seeking through G{beta}{gamma}
PNAS, August 26, 2008; 105(34): 12533 - 12538.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Thomas, G. G. Tall, A. Adhikari, and S. R. Sprang
Ric-8A Catalyzes Guanine Nucleotide Exchange on G{alpha}i1 Bound to the GPR/GoLoco Exchange Inhibitor AGS3
J. Biol. Chem., August 22, 2008; 283(34): 23150 - 23160.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Groves, Q. Gong, Z. Xu, C. Huntsman, C. Nguyen, D. Li, and D. Ma
A specific role of AGS3 in the surface expression of plasma membrane proteins
PNAS, November 13, 2007; 104(46): 18103 - 18108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yuan, M. Sato, S. M. Lanier, and A. V. Smrcka
Signaling by a Non-dissociated Complex of G Protein beta{gamma} and {alpha} Subunits Stimulated by a Receptor-independent Activator of G Protein Signaling, AGS8
J. Biol. Chem., July 6, 2007; 282(27): 19938 - 19947.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
A. Nishimura, M. Okamoto, Y. Sugawara, N. Mizuno, J. Yamauchi, and H. Itoh
Ric-8A potentiates Gq-mediated signal transduction by acting downstream of G protein-coupled receptor in intact cells.
Genes Cells, May 1, 2006; 11(5): 487 - 498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. W. Ja, A. Adhikari, R. J. Austin, S. R. Sprang, and R. W. Roberts
A Peptide Core Motif for Binding to Heterotrimeric G Protein {alpha} Subunits
J. Biol. Chem., September 16, 2005; 280(37): 32057 - 32060.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Malik, M. Ghosh, T. M. Bonacci, G. G. Tall, and A. V. Smrcka
Ric-8 Enhances G Protein {beta}{gamma}-Dependent Signaling in Response to {beta}{gamma}-Binding Peptides in Intact Cells
Mol. Pharmacol., July 1, 2005; 68(1): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. S. Nair, A. Mendez, J. B. Blumer, D. H. Rosenzweig, and V. Z. Slepak
The Presence of a Leu-Gly-Asn Repeat-Enriched Protein (LGN), a Putative Binding Partner of Transducin, in ROD Photoreceptors
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Mittal and M. E. Linder
The RGS14 GoLoco Domain Discriminates among G{alpha}i Isoforms
J. Biol. Chem., November 5, 2004; 279(45): 46772 - 46778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Cao, M. J. Cismowski, M. Sato, J. B. Blumer, and S. M. Lanier
Identification and Characterization of AGS4: A PROTEIN CONTAINING THREE G-PROTEIN REGULATORY MOTIFS THAT REGULATE THE ACTIVATION STATE OF Gi{alpha}
J. Biol. Chem., June 25, 2004; 279(26): 27567 - 27574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sato, T. W. Gettys, and S. M. Lanier
AGS3 and Signal Integration by G{alpha}s- and G{alpha}i-coupled Receptors: AGS3 BLOCKS THE SENSITIZATION OF ADENYLYL CYCLASE FOLLOWING PROLONGED STIMULATION OF A G{alpha}i-COUPLED RECEPTOR BY INFLUENCING PROCESSING OF G{alpha}i
J. Biol. Chem., April 2, 2004; 279(14): 13375 - 13382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Adhikari and S. R. Sprang
Thermodynamic Characterization of the Binding of Activator of G Protein Signaling 3 (AGS3) and Peptides Derived from AGS3 with G{alpha}i1
J. Biol. Chem., December 19, 2003; 278(51): 51825 - 51832.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ghosh, Y. K. Peterson, S. M. Lanier, and A. V. Smrcka
Receptor- and Nucleotide Exchange-independent Mechanisms for Promoting G Protein Subunit Dissociation
J. Biol. Chem., September 12, 2003; 278(37): 34747 - 34750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Kaushik, F. Yu, W. Chia, X. Yang, and S. Bahri
Subcellular Localization of LGN During Mitosis: Evidence for Its Cortical Localization in Mitotic Cell Culture Systems and Its Requirement for Normal Cell Cycle Progression
Mol. Biol. Cell, August 1, 2003; 14(8): 3144 - 3155.
[Abstract] [Full Text] [PDF]